Mitsue Inomata on Muck Rack

Mitsue Inomata

As seen in: Color Research & Application
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mitsue

Contact Mitsue, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rapid reduction of BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients

|
By Motohiro Shindo, Takeshi Kondo, Satoshi Yamamoto, Tatsuo Oyake, Kazunori Murai, Kohei Yamaguchi, Shigeki Ito, Takuto Miyagishima, Kentaro Wakasa, Mitsue Inomata, Takahiro Nagashima, Nozomu Fujimoto, Masakatsu Yonezumi, Kowata Shugo, Yasuhiko Tsukushi
| Color Research & Application
We conducted a phase-II study to evaluate the efficacy and safety of dasatinib in patients newly diagnosed with chronic-phase chronic myeloid leukaemia (CML-CP) in Japan (IMIDAS PART 2 study). We examined pre-treatment and post-treatment influences of various factors.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Mitsue

Contact Mitsue, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified